Current status of interventional therapy for acute pulmonary thromboembolism
10.3969/j.issn.1008-794X.2024.09.020
- VernacularTitle:急性肺血栓栓塞症介入治疗现状
- Author:
Xuezhi HOU
1
;
Qiang HUANG
Author Information
1. 810000 青海西宁 青海省人民医院
- Keywords:
acute pulmonary thromboembolism;
risk stratification;
catheter-directed thrombolysis;
transcatheter thrombectomy
- From:
Journal of Interventional Radiology
2024;33(9):1027-1033
- CountryChina
- Language:Chinese
-
Abstract:
The risk stratification of acute pulmonary thromboembolism(PTE)is the direction of treatment,and corresponding treatment plans are adopted for patients with different risk stratification.Anticoagulant therapy is the cornerstone of the treatment of acute PTE,but simple anticoagulant therapy is associated with an increased risk of early hemodynamic decompensation and death in the medium to high-risk population.Systematic thrombolysis can quickly reduce the burden of thrombus,alleviate right ventricular dysfunction,and improve hemodynamics earlier,but there is a high risk of bleeding.At present,catheter interventional therapy is rapidly developing and many matching devices have been developed,which aims to better formulate the treatment plan for acute PTE and to better meet the clinical requirements for the treatment of PTE.This article,based on the therapeutic idea of risk stratification,aims to make a comprehensive review about the different types of mechanical thrombectomy devices,inhalation thrombectomy devices and lytic thrombectomy devices,which are currently used in clinical treatment of PTE,although a comparative study on the advantages of their clinical application has not been conducted yet.The advantages and trends of their respective applications are discussed so as to provide a systematic summary of the current academic research in this field.
